BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 32046246)

  • 1. New Herbal Biomedicines for the Topical Treatment of Dermatological Disorders.
    Hoffmann J; Gendrisch F; Schempp CM; Wölfle U
    Biomedicines; 2020 Feb; 8(2):. PubMed ID: 32046246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which plant for which skin disease? Part 1: Atopic dermatitis, psoriasis, acne, condyloma and herpes simplex.
    Reuter J; Wölfle U; Weckesser S; Schempp C
    J Dtsch Dermatol Ges; 2010 Oct; 8(10):788-96. PubMed ID: 20707875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical application of St. John's wort (Hypericum perforatum).
    Wölfle U; Seelinger G; Schempp CM
    Planta Med; 2014 Feb; 80(2-3):109-20. PubMed ID: 24214835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [St. John's wort (Hypericum perforatum L.). A plant with relevance for dermatology].
    Schempp CM; Müller KA; Winghofer B; Schöpf E; Simon JC
    Hautarzt; 2002 May; 53(5):316-21. PubMed ID: 12063742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Which plant for which skin disease? Part 2: Dermatophytes, chronic venous insufficiency, photoprotection, actinic keratoses, vitiligo, hair loss, cosmetic indications.
    Reuter J; Wölfle U; Korting HC; Schempp C
    J Dtsch Dermatol Ges; 2010 Nov; 8(11):866-73. PubMed ID: 20707877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).
    Markowitz JS; DeVane CL
    Psychopharmacol Bull; 2001; 35(1):53-64. PubMed ID: 12397870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of total hypericins in St. John's wort and herbal medicinal products.
    Anyzewska M; Kowalczuk A; Łozak A; Jabłczyńska R; Fijałek Z
    Acta Pol Pharm; 2010; 67(6):586-92. PubMed ID: 21229872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of St.John's wort (Hypericum perforatum) oily extract for the care and treatment of pressure sores; a case report.
    Yücel A; Kan Y; Yesilada E; Akın O
    J Ethnopharmacol; 2017 Jan; 196():236-241. PubMed ID: 28011162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicinal plants as therapeutic options for topical treatment in canine dermatology? A systematic review.
    Tresch M; Mevissen M; Ayrle H; Melzig M; Roosje P; Walkenhorst M
    BMC Vet Res; 2019 May; 15(1):174. PubMed ID: 31133058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current St John's wort research from mode of action to clinical efficacy.
    Müller WE
    Pharmacol Res; 2003 Feb; 47(2):101-9. PubMed ID: 12543057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.
    Chrubasik-Hausmann S; Vlachojannis J; McLachlan AJ
    J Pharm Pharmacol; 2019 Jan; 71(1):129-138. PubMed ID: 29411879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endemic North American Plants as Potentially Suitable Agents for Wound Cleaning Under Resource Scarce Conditions.
    Whitehead AJ; Nelson NW; Brame LS; Champlin FR
    Wilderness Environ Med; 2019 Dec; 30(4):401-406. PubMed ID: 31630959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herbal supplements and therapeutic drug monitoring: focus on digoxin immunoassays and interactions with St. John's wort.
    Dasgupta A
    Ther Drug Monit; 2008 Apr; 30(2):212-7. PubMed ID: 18367983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic interactions of drugs with St John's wort.
    Zhou S; Chan E; Pan SQ; Huang M; Lee EJ
    J Psychopharmacol; 2004 Jun; 18(2):262-76. PubMed ID: 15260917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical application of St John's wort (Hypericum perforatum L.) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells.
    Schempp CM; Winghofer B; Lüdtke R; Simon-Haarhaus B; Schöpf E; Simon JC
    Br J Dermatol; 2000 May; 142(5):979-84. PubMed ID: 10809859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of self-administered St. John's wort for depression symptom management.
    Boehnlein B; Oakley LD
    J Am Acad Nurse Pract; 2002 Oct; 14(10):443-8. PubMed ID: 12426801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of topical application of Hypericum perforatum extract (St. John's wort) on skin sensitivity to solar simulated radiation.
    Schempp CM; Lüdtke R; Winghofer B; Simon JC
    Photodermatol Photoimmunol Photomed; 2000 Jun; 16(3):125-8. PubMed ID: 10885442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botanicals in dermatology: an evidence-based review.
    Reuter J; Merfort I; Schempp CM
    Am J Clin Dermatol; 2010; 11(4):247-67. PubMed ID: 20509719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. St John's wort (Hypericum perforatum) in major depression.
    Shelton RC
    J Clin Psychiatry; 2009; 70 Suppl 5():23-7. PubMed ID: 19909690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole.
    Wang LS; Zhou G; Zhu B; Wu J; Wang JG; Abd El-Aty AM; Li T; Liu J; Yang TL; Wang D; Zhong XY; Zhou HH
    Clin Pharmacol Ther; 2004 Mar; 75(3):191-7. PubMed ID: 15001970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.